Apyx director exercises 12,000 options via net share
Apyx Medical Corp director Lawrence Waldman reported a routine stock option exercise with tax withholding.
Rhea-AI Filing Summary
Apyx Medical Corp director Lawrence Waldman reported a routine stock option exercise with tax withholding. On June 30, 2026, a Spousal Lifetime Access Trust associated with him exercised 12,000 stock options at an exercise price of $1.88 per share. Under the net exercise terms, 5,024 shares that would have been issued were instead withheld by the company at a value of $4.49 per share to cover the aggregate exercise price, and 6,976 net shares were issued. Following these transactions, the filing shows 37,563 common shares held directly and 12,314 shares held indirectly through the trust, while the exercised option grant was reduced to zero. The footnotes state the trust is a Spousal Lifetime Access Trust and that Waldman disclaims beneficial ownership of its holdings except for any pecuniary interest.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock option (right to buy) | 12,000 | $0.00 | $0.00 |
| Exercise | Common Stock | 12,000 | $1.88 | $23K |
| Exercise Price or Tax Liability | Common Stock | 5,024 | $4.49 | $23K |
| holding | Common Stock | -- | -- | -- |
Footnotes (2)
- F1. Held by a Spousal Lifetime Access Trust (the "SLAT"). The Reporting Person's spouse and children are trustees of the SLAT. The Reporting Person disclaims beneficial ownership of all securities held by the SLAT, and this report should not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of the Reporting Person's pecuniary interest therein, if any.
- F2. On June 30, 2026, the Reporting Person effected a net exercise of 12,000 stock options with an exercise price of $1.88 per share. Pursuant to the terms of the exercise, 5,024 shares otherwise issuable upon exercise were withheld by the issuer at a value of $4.49 per share to satisfy the aggregate exercise price, resulting in the issuance of 6,976 net shares to the Reporting Person.
Key Figures
Key Terms
Spousal Lifetime Access Trust financial
net exercise financial
pecuniary interest financial
Section 16 regulatory
tax-withholding disposition financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Apyx Medical (APYX) director Lawrence Waldman report?
How many Apyx Medical (APYX) options did the trust associated with Waldman exercise?
How were taxes or exercise costs satisfied in this Apyx Medical (APYX) Form 4?
AI-generated analysis. How Rhea-AI works. Not financial advice.